TerrAscend (TSNDF) Shares Outstanding (Diluted Average) (2020 - 2026)

TerrAscend (TSNDF) reported Shares Outstanding (Diluted Average) of $308.5 million for Q1 2026, up 5.26% year-over-year from $293.1 million in Q1 2025, and up 2.47% quarter-over-quarter from $301.1 million in Q4 2025.

TerrAscend (TSNDF) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $308.5 million in Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $308.5 million, up 5.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $308.5 million (up 5.26% YoY), and the FY2025 annual result was $301.1 million, up 3.28% from the prior year.
  • Shares Outstanding (Diluted Average) grew to $308.5 million in Q1 2026 per TSNDF's latest filing, from $301.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $308.5 million in Q1 2026 and troughed at $211.1 million in Q1 2022.
  • A 5-year average of $277.0 million and a median of $290.6 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) slumped 99.88% in 2022, then gained 26.56% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $244.4 million in 2022, then climbed by 14.3% to $279.3 million in 2023, then advanced by 4.38% to $291.5 million in 2024, then rose by 3.28% to $301.1 million in 2025, then rose by 2.47% to $308.5 million in 2026.
  • Business Quant data shows TSNDF's Shares Outstanding (Diluted Average) at $308.5 million in Q1 2026, $301.1 million in Q4 2025, and $306.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 TerrAscend - - 34.60 Mn 308.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 308.53 Mn
Dec 31, 2025 301.08 Mn
Sep 30, 2025 306.30 Mn
Jun 30, 2025 296.14 Mn
Mar 31, 2025 293.12 Mn
Dec 31, 2024 291.51 Mn
Sep 30, 2024 291.25 Mn
Jun 30, 2024 291.05 Mn
Mar 31, 2024 290.62 Mn
Dec 31, 2023 279.29 Mn
Sep 30, 2023 276.56 Mn
Jun 30, 2023 275.19 Mn
Mar 31, 2023 267.21 Mn
Dec 31, 2022 244.35 Mn
Sep 30, 2022 254.36 Mn
Jun 30, 2022 231.83 Mn
Mar 31, 2022 211.13 Mn
Dec 31, 2021 208.71 Mn
Sep 30, 2021 214.76 Bn
Jun 30, 2021 176.90 Bn